Cargando…
A Combined Screening Platform for HIV Treatment Failure and Resistance
BACKGROUND: To develop a low cost method to screen for virologic failure of antiretroviral therapy (ART) and HIV-1 drug resistance, we performed a retrospective evaluation of a screening assay using serial dilutions of HIV-1 RNA-spiked blood plasma and samples from patients receiving >6 months of...
Autores principales: | Tilghman, Myres W., May, Susanne, Pérez-Santiago, Josué, Ignacio, Caroline C., Little, Susan J., Richman, Douglas D., Smith, Davey M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338506/ https://www.ncbi.nlm.nih.gov/pubmed/22563383 http://dx.doi.org/10.1371/journal.pone.0035401 |
Ejemplares similares
-
Optimizing Screening for HIV
por: Chaillon, Antoine, et al.
Publicado: (2020) -
HIV-1 Clade B pol Evolution following Primary Infection
por: Hightower, George K., et al.
Publicado: (2013) -
Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy
por: Massanella, Marta, et al.
Publicado: (2015) -
Characterizing the multiplicity of HIV founder variants during sexual transmission among MSM
por: Chaillon, Antoine, et al.
Publicado: (2016) -
A randomized controlled clinical trial on the impact of CCR5 blockade with maraviroc in early infection on T-cell dynamics
por: Karris, Maile Y., et al.
Publicado: (2016)